Abel1950 Inc.

CIK: 2075910•CA•Incorporated: 2010-03-09

Latest Reported Offering

$25,000
Target Amount
$100,000
Maximum Amount
2025-09-19
Deadline

Security Details

Type: Debt
Price per share: $1.00
Price set by: Pro-rated portion of the total principal
Shares offered: 0+

Offering Costs

Cash commission: 8.5%
of the total offering amount upon a successful raise. Platform Fee corresponding to selected level of service. 3% investment fee capped at $50. Credit Card: 4.5%, capped at $1,000. Honeycomb Wallet: 0%; Hybrid (HW + ACH): 2%, capped at $30
Equity compensation: —
None

Filing history

Form C family — 3 filings
FiledFormFile numberPortalWhat it statesWhat the filer said
2025-10-08C-U020-36162Honeycomb$25K target, up to $100K · Debt at $1.00 · closes 2025-09-19Total Amount Raised: $26,965.83
2025-09-08C/A020-36162Honeycomb$25K target, up to $100K · Debt at $1.00 · closes 2025-09-19Extend Target Deadline and lower Target amount
2025-07-17C020-36162Honeycomb$50K target, up to $100K · Debt at $1.00 · closes 2025-09-04—
Embarc dashboard

Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.

  • Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
  • A sparkline on each figure so the shape is visible before the numbers
  • A revenue series dated to the filings that reported it
  • The campaign as filed: target, ceiling, deadline, and the portal that ran it
  • Follow it, and see it change on your watchlist
Open in the dashboard

Company Information

Legal Status
Corporation
Jurisdiction
CA
Date of Incorporation
2010-03-09

Latest Metrics

Employees10
Total Assets$74,772
Cash on Hand$48,772
Revenues$195,003
Net Income$59,466

Crowdfunding Portals

The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.